A form of dropless vitrectomy helped control intraocular inflammation and prevent infection after surgery for vitreous hemorrhage secondary to proliferative diabetic retinopathy, according to a study.
In a presentation at the American Society of Retina Specialists meeting, K.V. Chalam, MD, PhD, MBA, FASRS, said his center has been performing dropless cataract surgery for about 6 years with good success rates.
“For 3 or 4 years, we have been doing vitrectomy surgery as well,” he said.
Chalam and colleagues conducted a retrospective chart review that included 412 consecutive patients.